Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 9 studies | 34% ± 11% | |
| duct epithelial cell | 4 studies | 56% ± 9% | |
| basal cell | 4 studies | 44% ± 25% | |
| epithelial cell | 3 studies | 21% ± 3% | |
| respiratory goblet cell | 3 studies | 33% ± 19% | |
| secretory cell | 3 studies | 53% ± 23% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 31% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 99% | 332160.54 | 224 / 226 | 73% | 140.68 | 298 / 406 |
| breast | 94% | 6650.78 | 430 / 459 | 44% | 7.19 | 492 / 1118 |
| lung | 44% | 739.94 | 255 / 578 | 45% | 5.48 | 516 / 1155 |
| adipose | 76% | 5085.05 | 911 / 1204 | 0% | 0 | 0 / 0 |
| esophagus | 17% | 224.62 | 251 / 1445 | 56% | 7.79 | 102 / 183 |
| pancreas | 14% | 93.05 | 45 / 328 | 55% | 5.22 | 98 / 178 |
| muscle | 53% | 2858.62 | 426 / 803 | 0% | 0 | 0 / 0 |
| stomach | 16% | 264.48 | 57 / 359 | 35% | 7.79 | 100 / 286 |
| kidney | 24% | 215.71 | 21 / 89 | 25% | 8.08 | 225 / 901 |
| intestine | 11% | 161.32 | 106 / 966 | 34% | 5.40 | 181 / 527 |
| uterus | 5% | 28.64 | 8 / 170 | 40% | 6.22 | 185 / 459 |
| prostate | 25% | 778.76 | 62 / 245 | 20% | 2.46 | 98 / 502 |
| bladder | 14% | 343.67 | 3 / 21 | 27% | 4.13 | 138 / 504 |
| adrenal gland | 36% | 274.85 | 94 / 258 | 1% | 0.04 | 2 / 230 |
| skin | 33% | 335.94 | 588 / 1809 | 3% | 0.28 | 16 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 36% | 1.56 | 16 / 45 |
| blood vessel | 32% | 491.39 | 421 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 10% | 108.52 | 66 / 653 | 14% | 1.93 | 86 / 605 |
| ovary | 2% | 6.00 | 3 / 180 | 21% | 2.11 | 89 / 430 |
| brain | 1% | 2.49 | 17 / 2642 | 9% | 2.02 | 65 / 705 |
| peripheral blood | 8% | 447.61 | 71 / 929 | 0% | 0 | 0 / 0 |
| heart | 7% | 53.28 | 57 / 861 | 0% | 0 | 0 / 0 |
| spleen | 4% | 432.29 | 9 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006953 | Biological process | acute-phase response |
| GO_0034364 | Cellular component | high-density lipoprotein particle |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SAA2 |
| Protein name | Serum amyloid A protein Alternative protein SAA2 Serum amyloid A-2 protein (SAA2) [Cleaved into: Amyloid A2 protein (AA2)] |
| Synonyms | hCG_1991504 |
| Description | FUNCTION: Major acute phase reactant. . FUNCTION: Major acute phase reactant. Apolipoprotein of the HDL complex. . FUNCTION: Major acute phase reactant. Apolipoprotein of the HDL complex. . |
| Accessions | ENST00000528349.5 ENST00000256733.9 [P0DJI9-1] ENST00000526900.1 [P0DJI9-1] P0DJI9 E9PR14 ENST00000530400.5 ENST00000529528.5 [P0DJI9-1] G3V1D9 L8E762 ENST00000414546.6 [P0DJI9-2] |
